Kestra Medical Technologies (KMTS) Competitors $25.74 +0.19 (+0.74%) As of 09/23/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock KMTS vs. GKOS, TMDX, NVST, LIVN, WRBY, SLNO, INSP, EYE, LMAT, and PRCTShould you be buying Kestra Medical Technologies stock or one of its competitors? The main competitors of Kestra Medical Technologies include Glaukos (GKOS), TransMedics Group (TMDX), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), National Vision (EYE), LeMaitre Vascular (LMAT), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry. Kestra Medical Technologies vs. Its Competitors Glaukos TransMedics Group Envista LivaNova Warby Parker Soleno Therapeutics Inspire Medical Systems National Vision LeMaitre Vascular PROCEPT BioRobotics Glaukos (NYSE:GKOS) and Kestra Medical Technologies (NASDAQ:KMTS) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings. Which has stronger earnings & valuation, GKOS or KMTS? Kestra Medical Technologies has lower revenue, but higher earnings than Glaukos. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlaukos$432.95M11.21-$146.37M-$1.65-51.31Kestra Medical Technologies$66.40M19.94-$113.81MN/AN/A Does the media prefer GKOS or KMTS? In the previous week, Kestra Medical Technologies had 1 more articles in the media than Glaukos. MarketBeat recorded 9 mentions for Kestra Medical Technologies and 8 mentions for Glaukos. Glaukos' average media sentiment score of 0.72 beat Kestra Medical Technologies' score of 0.40 indicating that Glaukos is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Glaukos 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Kestra Medical Technologies 2 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend GKOS or KMTS? Glaukos presently has a consensus price target of $123.58, suggesting a potential upside of 45.98%. Kestra Medical Technologies has a consensus price target of $27.33, suggesting a potential upside of 6.19%. Given Glaukos' higher probable upside, analysts clearly believe Glaukos is more favorable than Kestra Medical Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Glaukos 1 Sell rating(s) 2 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.79Kestra Medical Technologies 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 Is GKOS or KMTS more profitable? Kestra Medical Technologies has a net margin of 0.00% compared to Glaukos' net margin of -21.43%. Kestra Medical Technologies' return on equity of 0.00% beat Glaukos' return on equity.Company Net Margins Return on Equity Return on Assets Glaukos-21.43% -8.59% -6.61% Kestra Medical Technologies N/A N/A N/A Do institutionals and insiders hold more shares of GKOS or KMTS? 99.0% of Glaukos shares are owned by institutional investors. 6.4% of Glaukos shares are owned by insiders. Comparatively, 3.6% of Kestra Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryGlaukos and Kestra Medical Technologies tied by winning 7 of the 14 factors compared between the two stocks. Get Kestra Medical Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for KMTS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KMTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KMTS vs. The Competition Export to ExcelMetricKestra Medical TechnologiesMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.31B$10.70B$5.76B$10.51BDividend YieldN/A1.90%5.53%4.57%P/E RatioN/A20.5976.0626.61Price / Sales19.9438.02472.8291.51Price / CashN/A24.5937.4661.85Price / Book7.193.4013.586.45Net Income-$113.81M$212.47M$3.29B$271.57M7 Day Performance8.47%0.14%1.83%2.61%1 Month Performance38.54%-2.71%4.02%7.28%1 Year PerformanceN/A-10.38%77.05%29.60% Kestra Medical Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KMTSKestra Medical Technologies0.6205 of 5 stars$25.74+0.7%$27.33+6.2%N/A$1.31B$66.40M0.00300Positive NewsGKOSGlaukos4.5572 of 5 stars$83.43-2.8%$124.83+49.6%-33.9%$4.78B$383.48M-50.56780Analyst ForecastTMDXTransMedics Group2.3522 of 5 stars$122.29+1.0%$125.40+2.5%-24.4%$4.17B$531.29M63.36210NVSTEnvista3.7758 of 5 stars$20.91-0.6%$20.92+0.1%+9.5%$3.47B$2.55B65.3512,300Positive NewsLIVNLivaNova2.9077 of 5 stars$55.00-1.6%$59.71+8.6%+5.2%$3.00B$1.31B-14.142,900Positive NewsWRBYWarby Parker1.4783 of 5 stars$28.48+0.5%$24.06-15.5%+95.6%$3.00B$821.35M-406.803,780SLNOSoleno Therapeutics4.444 of 5 stars$54.74-3.3%$115.09+110.3%+18.1%$2.91BN/A-13.2230High Trading VolumeINSPInspire Medical Systems4.8044 of 5 stars$79.86-4.2%$164.50+106.0%-64.5%$2.36B$861.31M46.161,246Analyst DowngradeHigh Trading VolumeEYENational Vision2.2047 of 5 stars$26.92+1.9%$24.73-8.1%+157.6%$2.13B$1.82B-149.5613,411High Trading VolumeLMATLeMaitre Vascular3.2746 of 5 stars$92.25-1.3%$97.60+5.8%-1.7%$2.09B$219.86M44.78490Positive NewsAnalyst ForecastHigh Trading VolumePRCTPROCEPT BioRobotics2.7764 of 5 stars$37.39-1.7%$70.00+87.2%-51.2%$2.08B$224.50M-24.12430 Related Companies and Tools Related Companies GKOS Alternatives TMDX Alternatives NVST Alternatives LIVN Alternatives WRBY Alternatives SLNO Alternatives INSP Alternatives EYE Alternatives LMAT Alternatives PRCT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KMTS) was last updated on 9/24/2025 by MarketBeat.com Staff From Our PartnersWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredIs This Nvidia’s Next Big Invention? (Picture Inside)Nvidia gave investors a chance to make more than 150 times their money with its AI chips known as graphic proc...InvestorPlace | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kestra Medical Technologies, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kestra Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
